To hear about similar clinical trials, please enter your email below
Trial Title:
Stress Management Intervention Among Breast and Gynecologic Cancer Patients in Viet Nam
NCT ID:
NCT06398067
Condition:
Breast Cancer
Gynecologic Cancer
Conditions: Keywords:
Self-Help Plus (SH+)
Stress management
Viet Nam
World Health Organization
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Intervention model description:
A 2-arm, parallel, single-blind randomized controlled trial (RCT).
Primary purpose:
Prevention
Masking:
Single (Participant)
Intervention:
Intervention type:
Behavioral
Intervention name:
Vietnamese Self-Help Plus (vSH+)
Description:
vSH+ is a stress management program delivered through four 75-minute sessions. It
includes the five core SH+ skills. Healthcare workers (nurses and social workers)
function as lead facilitators (called 'HW Facilitators') and cancer survivors as
co-facilitators (called 'Peer Facilitators').
Arm group label:
Vietnamese Self-Help Plus (vSH+)
Intervention type:
Other
Intervention name:
'Doing What Matters in Times of Stress' (DWM) Guide
Description:
An illustrated guide developed by WHO to equip people with practical skills to help cope
with stress which has been translated to Vietnamese and reviewed and revised by the
investigators.
Arm group label:
Enhanced Usual Care
Arm group label:
Vietnamese Self-Help Plus (vSH+)
Summary:
Psychological distress is common among Vietnamese cancer patients but often
underestimated and not detected by professionals due to lack of time and overload of
clinical work. Currently no established, evidence-based intervention exists to help
address the mental health needs of cancer patients in Viet Nam besides the 'Stronger
Together' peer mentoring intervention model that the investigators piloted in 2021-2023.
The goal of this 2-arm, parallel, single-blind randomized controlled trial (RCT) is to
pilot and evaluate the Vietnamese Self Help Plus (vSH+) stress management intervention
among breast and gynecologic cancer patients in Viet Nam.
Aim 1- the investigators pilot the adapted vSH+ intervention. After recruitment and
screening, participants are randomized into either the intervention (vSH+) or enhanced
usual care (EUC) study arms. Participants are invited to attend an in-person
informational session (IS) specific to their study arm, where informed consent is
obtained.
Aim 2- the investigators assess the potential effectiveness of the vSH+ intervention.
Quantitative surveys of study outcomes measures are administered at three timepoints: T0
(baseline, in-person, during info-sessions); T1 (1-2 weeks post-intervention, via phone);
and T2 (3 months post-intervention, via phone).
Aim 3- the investigators conduct a qualitative process evaluation, via in-depth interview
(IDIs) and focus group discussions (FGDs), to assess the acceptability and feasibility
implementing and scaling up the vSH+ intervention model. Satisfaction surveys will be
administered during vSH+ sessions and in-depth interviews (IDIs) will be conducted
following the conclusion of the intervention. IDIs wil also be conducted with
Facilitators, in addition to evaluation surveys during vSH+ sessions and supportive
supervision sessions. Between T1 and T2, the investigators will conduct IDIs with
Healthcare Workers and focus group discussions with Caregivers.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Aged 18 years or older
- Have a clinician-confirmed diagnosis within the past 12 months of first-time breast
and/or gynecologic cancer (e.g., cervical, ovarian, uterine, vaginal, vulvar) in
stages I-III
- Currently or will receive treatment with curative intent
- Score less than 8 on the National Comprehensive Cancer Network (NCCN) Distress
Thermometer, indicating low to moderate levels of distress
- Score less than 15 on the Patient Health Questionnaire-9 items (PHQ-9, indicating
low to moderate levels of depression
Exclusion Criteria:
- Selected '2 Several days' or '3 Almost everyday' on PHQ9 item #9, indicating
indicating imminent risk of suicide
- Have severe chronic diseases (e.g., coronary heart disease, chronic obstructive
pulmonary disease (COPD), chronic renal failure), at the discretion of the treating
clinician or study investigator
- People with a risk for psychosis, mania, and alcohol abuse, based on screening
questions commonly used in the field
- Cannot attend the intervention activities at the hospital during the proposed
intervention period
Gender:
Female
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Can Tho Oncology Hospital
Address:
City:
Can Tho
Country:
Vietnam
Status:
Recruiting
Facility:
Name:
Oncology Center, Cho Ray Hospital
Address:
City:
Cho Ray
Country:
Vietnam
Status:
Recruiting
Facility:
Name:
Da Nang Oncology Hospital
Address:
City:
Da Nang
Country:
Vietnam
Status:
Recruiting
Facility:
Name:
Breast and Gynecology Department, Hung Vuong Women's Hospital
Address:
City:
Ho Chi Minh
Country:
Vietnam
Status:
Recruiting
Facility:
Name:
Ho Chi Minh City Oncology Hospital
Address:
City:
Ho Chi Minh
Country:
Vietnam
Status:
Recruiting
Facility:
Name:
Oncology Center, Hue Central Hospital
Address:
City:
Hue
Country:
Vietnam
Status:
Recruiting
Start date:
November 5, 2024
Completion date:
December 2026
Lead sponsor:
Agency:
Boston University
Agency class:
Other
Collaborator:
Agency:
Fogarty International Center of the National Institute of Health
Agency class:
NIH
Source:
Boston University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06398067